Literature DB >> 33771907

Imaging of Small Intestine Neuroendocrine Neoplasms: Is SSTR PET the Holy Grail?

Alessio Imperiale1, Leah Meuter2, Karel Pacak2, David Taïeb3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33771907      PMCID： PMC8724890          DOI： 10.2967/jnumed.121.262140

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  10 in total

1.  ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.

Authors:  B Niederle; U-F Pape; F Costa; D Gross; F Kelestimur; U Knigge; K Öberg; M Pavel; A Perren; C Toumpanakis; J O'Connor; D O'Toole; E Krenning; N Reed; R Kianmanesh
Journal:  Neuroendocrinology       Date:  2016-01-12       Impact factor: 4.914

2.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Authors:  Anders Sundin; Rudolf Arnold; Eric Baudin; Jaroslaw B Cwikla; Barbro Eriksson; Stefano Fanti; Nicola Fazio; Francesco Giammarile; Rodney J Hicks; Andreas Kjaer; Eric Krenning; Dik Kwekkeboom; Catherine Lombard-Bohas; Juan M O'Connor; Dermot O'Toole; Andrea Rockall; Bertram Wiedenmann; Juan W Valle; Marie-Pierre Vullierme
Journal:  Neuroendocrinology       Date:  2017-03-30       Impact factor: 4.914

3.  Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.

Authors:  Emile B Veenstra; Derk Jan A de Groot; Adrienne H Brouwers; Annemiek M E Walenkamp; Walter Noordzij
Journal:  Clin Nucl Med       Date:  2021-03-01       Impact factor: 7.794

4.  Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.

Authors:  Catherine Ansquer; Yann Touchefeu; Alain Faivre-Chauvet; Christophe Leux; Maëlle Le Bras; Nicolas Régenet; Vincent Fleury; Bruno Maucherat; Hélène Senellart; Serge Guyetant; Thomas Carlier; Evelyne Scotet-Cérato; Aurore Rauscher; Eric Frampas; Françoise Kraeber-Bodéré
Journal:  Clin Nucl Med       Date:  2021-03-01       Impact factor: 7.794

5.  Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Authors:  Murat Fani Bozkurt; Irene Virgolini; Sona Balogova; Mohsen Beheshti; Domenico Rubello; Clemens Decristoforo; Valentina Ambrosini; Andreas Kjaer; Roberto Delgado-Bolton; Jolanta Kunikowska; Wim J G Oyen; Arturo Chiti; Francesco Giammarile; Anders Sundin; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-25       Impact factor: 9.236

6.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

7.  Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.

Authors:  D Putzer; M Gabriel; D Kendler; B Henninger; M Knoflach; A Kroiss; E Vonguggenberg; B Warwitz; I J Virgolini
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 2.346

8.  Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.

Authors:  Alexander Haug; Christoph J Auernhammer; Björn Wängler; Reinhold Tiling; Gerwin Schmidt; Burkhard Göke; Peter Bartenstein; Gabriele Pöpperl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

9.  Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.

Authors:  Valentina Ambrosini; Paola Tomassetti; Paolo Castellucci; Davide Campana; Giancarlo Montini; Domenico Rubello; Cristina Nanni; Anna Rizzello; Roberto Franchi; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

10.  Intraindividual comparison of 18 F-FDOPA and 68 Ga-DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.

Authors:  Eric Ouvrard; Elodie Chevalier; Pietro Addeo; Nicolas Sahakian; Julien Detour; Bernard Goichot; Philippe Bachellier; Gilles Karcher; David Taïeb; Alessio Imperiale
Journal:  Clin Endocrinol (Oxf)       Date:  2020-09-15       Impact factor: 3.478
  10 in total
  1 in total

1.  Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient's Favor.

Authors:  Karel Pacak; David Taieb; Abhishek Jha
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.